JP2015502356A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502356A5 JP2015502356A5 JP2014544935A JP2014544935A JP2015502356A5 JP 2015502356 A5 JP2015502356 A5 JP 2015502356A5 JP 2014544935 A JP2014544935 A JP 2014544935A JP 2014544935 A JP2014544935 A JP 2014544935A JP 2015502356 A5 JP2015502356 A5 JP 2015502356A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- reactivity
- cross
- less
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161565281P | 2011-11-30 | 2011-11-30 | |
| US61/565,281 | 2011-11-30 | ||
| US201261665686P | 2012-06-28 | 2012-06-28 | |
| US61/665,686 | 2012-06-28 | ||
| PCT/US2012/067353 WO2013082463A2 (en) | 2011-11-30 | 2012-11-30 | Assays, antibodies, immunogens and compositions related to 5-fu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502356A JP2015502356A (ja) | 2015-01-22 |
| JP2015502356A5 true JP2015502356A5 (enExample) | 2016-01-21 |
Family
ID=48536238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544935A Pending JP2015502356A (ja) | 2011-11-30 | 2012-11-30 | ５−ｆｕに関連するアッセイ、抗体、免疫原および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9702869B2 (enExample) |
| EP (1) | EP2785736A4 (enExample) |
| JP (1) | JP2015502356A (enExample) |
| AU (1) | AU2012327223A1 (enExample) |
| CA (1) | CA2857645A1 (enExample) |
| WO (1) | WO2013082463A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10401368B2 (en) | 2014-03-20 | 2019-09-03 | Pdl Biopharma, Inc. | Antibodies and methods for the detection of cell death |
| US11305010B2 (en) * | 2016-01-21 | 2022-04-19 | The Scripps Research Institute | Synthetic opioid vaccine |
| JP6218916B1 (ja) | 2016-12-28 | 2017-10-25 | Jsr株式会社 | 磁性粒子分散液 |
| JP7104911B2 (ja) * | 2018-01-31 | 2022-07-22 | 国立研究開発法人産業技術総合研究所 | 標的物質検出方法及び導波モードセンサ |
| CN111875587B (zh) * | 2020-07-23 | 2021-07-13 | 湖南苏阳医疗科技有限公司 | 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用 |
| JP2024501434A (ja) * | 2020-12-03 | 2024-01-12 | オルト－クリニカル ダイアグノスティックス インコーポレイテッド | 遮断剤としてのヘパリンリチウム |
| CN113501877A (zh) * | 2021-08-23 | 2021-10-15 | 苏州科铭生物技术有限公司 | 抗5-氟尿嘧啶单克隆抗体的制备方法、5-氟尿嘧啶的酶联免疫检测方法 |
| CN114487059B (zh) * | 2021-12-29 | 2022-11-25 | 苏州大学 | 一种电化学发光免疫传感器及其制备和应用 |
| JP7709140B2 (ja) * | 2022-03-01 | 2025-07-16 | 学校法人早稲田大学 | 小型非荷電分子の検出方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366862A (en) * | 1990-02-14 | 1994-11-22 | Receptor Laboratories, Inc. | Method for generating and screening useful peptides |
| US20030017147A1 (en) | 1996-09-20 | 2003-01-23 | Guy L Reed | Composition and method for enhancing fibrinolysis |
| DE10020376A1 (de) * | 2000-04-26 | 2001-11-08 | Inst Zelltechnologie E V | Dynamische Marker |
| WO2006044643A2 (en) * | 2004-10-15 | 2006-04-27 | Seattle Genetics, Inc. | Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| US20060177883A1 (en) | 2005-02-08 | 2006-08-10 | Saladax Biomedical Inc. | 5-Fluoro-uracil immunoassay |
| CN101925611A (zh) | 2007-11-21 | 2010-12-22 | 安姆根有限公司 | Wise结合剂和表位 |
| CN101461948B (zh) * | 2009-01-04 | 2011-12-14 | 广东药学院 | 一种叶酸介导的5-氟尿嘧啶白蛋白大分子前体药物及其制备方法和应用 |
| BRPI1009455A2 (pt) * | 2009-03-10 | 2016-03-01 | Baylor Res Inst | anticorpos anti-c40 e usos dos mesmos |
| CN108373509A (zh) * | 2009-03-10 | 2018-08-07 | 贝勒研究院 | 靶向抗原呈递细胞的抗病毒疫苗 |
| CA2685842A1 (en) * | 2009-07-16 | 2011-01-16 | University College Cork, National University Of Ireland, Cork | A method for the treatment of cancer |
| BR112012000873A2 (pt) | 2009-07-17 | 2019-11-05 | Myriad Genetics Inc | método de dosar 5-fluorouracil em uma amostra de um paciente tratado com f-fu ou um pró-fármaco deste, método de tratar um paciente com 5-fluorouracil ou um pró-fármaco deste, método de processamento de uma amostra de sangue de um paciente tratado com um regime compreendendo 5-fluorouracil ou um pró-fármaco deste para um teste de 5-fluorouracil, método de processamento de uma amostra de sangue de um paciente tratado com um regime compreendendo 5-fluorouracil ou um pró-fármaco deste, composição, kit, kit de teste, conjunto de seringa de transferência |
| WO2011072204A1 (en) * | 2009-12-10 | 2011-06-16 | Regeneron Pharmaceuticals, Inc. | Mice that make heavy chain antibodies |
-
2012
- 2012-11-30 AU AU2012327223A patent/AU2012327223A1/en not_active Abandoned
- 2012-11-30 US US14/361,731 patent/US9702869B2/en active Active
- 2012-11-30 JP JP2014544935A patent/JP2015502356A/ja active Pending
- 2012-11-30 WO PCT/US2012/067353 patent/WO2013082463A2/en not_active Ceased
- 2012-11-30 CA CA2857645A patent/CA2857645A1/en not_active Abandoned
- 2012-11-30 EP EP12852770.2A patent/EP2785736A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6715770B2 (ja) | モノクローナル抗ｔｋ１抗体 | |
| JP2020534830A5 (enExample) | ||
| JP2015535828A5 (enExample) | ||
| RU2015126533A (ru) | Анти-cd47 антитела и способы их применения | |
| RU2018108048A (ru) | Новые анти-pd-1 антитела | |
| JP2011217747A5 (enExample) | ||
| JP2013518903A5 (enExample) | ||
| FI2897981T3 (fi) | Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä | |
| JP2021511811A5 (enExample) | ||
| JP2016509585A5 (enExample) | ||
| JP2015533788A5 (enExample) | ||
| JP2014516540A5 (enExample) | ||
| JP2020537520A5 (enExample) | ||
| RU2012131671A (ru) | Способ полипептидной модификации для очистки полипептидных мультимеров | |
| RU2015129720A (ru) | Антитела к h7cr | |
| JP2014518883A5 (enExample) | ||
| US9702869B2 (en) | Assays, antibodies, immunogens and compositions related to 5-FU | |
| RU2014146707A (ru) | Антитела против тофацитиниба и их применение для лекарственного мониторинга | |
| MD3355919T2 (ro) | Terapie combinată cu utilizarea inhibitorilor factorului de creștere și diferențiere uman 15 (GDF-15) și a blocanților punctelor de control imunitar | |
| JP2013531655A5 (enExample) | ||
| Liu et al. | Development and evaluation of a novel in situ target-capture approach for aptamer selection of human noroviruses | |
| KR102390761B1 (ko) | HBsAg의 정량적 검출을 위한 키트 및 방법 | |
| JP2014518624A5 (enExample) | ||
| JP6457933B2 (ja) | インスリン測定方法 | |
| JP2020515286A5 (enExample) |